A new study has found that a simple blood test may be a powerful way to detect early signs of Alzheimer’s disease, even in ...

Cognitive decline can range from mild forgetfulness to serious memory problems like dementia, which can affect a person’s ...

Dementia is one of the leading causes of death in Australia but a new finding could revolutionise detection and treatment. American researchers analysed health data from 24,000 patients living with ...

Gabapentin, which is used to treat seizures, nerve pain and restless leg syndrome might be linked with increased risk of ...

The new dosing schedule with a more gradual titration significantly lowered incidence of ARIA-E in the TRAILBLAZER-ALZ 6 trial.

The Food and Drug Administration (FDA) has updated the labeling for Kisunla ™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer ...

A new dosing regimen for Kisunla, to help lower the risk of certain side effects, has been approved by the U.S. Food and Drug ...

A journey through the FDA’s newly released complete response letters gave glimpses into the journeys to market for Eli ...

A commonly prescribed pain medication—gabapentin—often considered a safer alternative to opioids for those who suffer from low back pain is now under scrutiny after being linked to increased risks of ...

Alzheimer’s and brain health deserve attention year-round, as millions are affected by dementia and related conditions.

Scientists at UCSF combined advanced brain-network modeling, genetics, and imaging to reveal how tau protein travels through ...

We spoke to the first author of a new study that could challenge much of what we thought we knew about Alzheimer’s disease.